Ye, Xiao-Fei
Miao, Chao-Ying
Zhang, Wei
Sheng, Chang-Sheng
Huang, Qi-Fang
Wang, Ji-Guang
Article History
Received: 12 April 2021
Accepted: 29 October 2021
First Online: 9 November 2021
Declarations
:
: This study was approved by the Ethics Committee of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. All methods were performed in accordance with the relevant guidelines and regulations. Informed consent was obtained from all participants and also from legally authorized representatively of deceased participants.
: Not applicable.
: Dr. Wang reports receiving lecture and consulting fees from Novartis, Omron, and Takeda. The other authors declared no conflicts of interest.